These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2396109)

  • 1. [Spectrum of erythrocyte membrane lipids in various types of hypoglycemic therapy].
    Kozlov GS; Buĭdina TA; Balabolkin MI
    Sov Med; 1990; (6):10-3. PubMed ID: 2396109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of diabeton and metformin on the free-radical oxidation processes and the structural characteristics of the phospholipid composition of the erythrocyte membranes in non-insulin-dependent diabetes mellitus].
    Buĭdina TA; Kozlov GS; Balabolkin MI
    Sov Med; 1991; (7):14-6. PubMed ID: 1948331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reclid effects on carbohydrate, lipid metabolism, lipid peroxidation and hemodynamics in patients with diabetes mellitus type 2].
    Shustov SB; Romashevskiĭ BV; Khalimov IuSh; Stepanova OIu; Lysenko AG
    Klin Med (Mosk); 2000; 78(11):45-8. PubMed ID: 11232532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compositional alterations of erythrocyte membrane lipid and red cell deformability in diabetes].
    Qiu H
    Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):21-3. PubMed ID: 1850649
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations of erythrocyte lipid pattern and of some membrane related functions as a consequence of plasma lipid disorder in diabetes mellitus.
    Cignarelli M; Blonda M; Cospite MR; Damato A; Nardelli G; Giorgino R
    Diabete Metab; 1983 Dec; 9(4):272-6. PubMed ID: 6667763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].
    Galeone F; Fiore G; Arcangeli A; Mannucci E
    Minerva Endocrinol; 1998 Sep; 23(3):71-5. PubMed ID: 10063324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
    Jennings PE; Belch JJ
    Ter Arkh; 2001; 73(4):27-31. PubMed ID: 11494442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.
    Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K
    J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of different pharmacological formulations of gliclazide on postprandial hyperglycaemia.
    Bardini G; Mannucci E; Rotella CM
    Diabet Med; 1998 Aug; 15(8):706. PubMed ID: 9702477
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in the lipid composition of red blood cells in hyperglycemic rats.
    Nehal M; Venugopal P; Baquer NZ
    Biochem Int; 1990 Oct; 22(2):243-8. PubMed ID: 2090094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
    Matthews DR; Charbonnel BH; Hanefeld M; Brunetti P; Schernthaner G
    Diabetes Metab Res Rev; 2005; 21(2):167-74. PubMed ID: 15386821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J; Soszyński P
    Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of thyroid hormones on the lipid composition of rat plasma and erythrocyte membranes.
    Digiorgio VM; Cafagna F; Ruggiero FM
    Boll Soc Ital Biol Sper; 1988 Nov; 64(11):979-84. PubMed ID: 3245915
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes of erythrocyte and platelet membrane lipid pattern in different subtypes of dementia].
    Chen C; Jia H; Ma H
    Zhonghua Yi Xue Za Zhi; 1998 Oct; 78(10):771-3. PubMed ID: 11038832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a 1-year period.
    Mozersky RP; Patel H; Bahl VK; Bahl S; Mook W
    J Am Osteopath Assoc; 1996 Jun; 96(6):346-51. PubMed ID: 8690621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily.
    Guillausseau PJ; Greb W
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):133-7. PubMed ID: 11353879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
    Martínez M; Vayá A; Server R; Gilsanz A; Aznar J
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):253-8. PubMed ID: 9741665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.